News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Rami Manochakian: U.S. FDA approves Amivantamab WITH CHEMOTHERAPY for 1st Line treatment of advanced non-small cell Lung Cancer with EGFR
Photo taken from Rami Manochakian/Twitter
Mar 6, 2024, 11:34

Rami Manochakian: U.S. FDA approves Amivantamab WITH CHEMOTHERAPY for 1st Line treatment of advanced non-small cell Lung Cancer with EGFR

Rami Manochakian, Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter:

“HOT OFF THE PRESS

U.S. FDA approves Amivantamab WITH CHEMOTHERAPY for 1stLine treatment of advanced non-small cell Lung Cancer with EGFR Exon20 mutations. Approval based on Papillion trial which showed increased mPFS compared with chemo alone: 11.4 vs 6.7 months.”

Rami Manochakian: U.S. FDA approves Amivantamab WITH CHEMOTHERAPY for 1st Line treatment of advanced non-small cell Lung Cancer with EGFR Rami Manochakian: U.S. FDA approves Amivantamab WITH CHEMOTHERAPY for 1st Line treatment of advanced non-small cell Lung Cancer with EGFR

Source: Rami Manochakian/X

Amivantamab cancer Lung cancer non small cell lung cancer OncoDaily Oncology Papillion trial Rami Manochakian
Special Coverage
Insight
Jun 2, 2025, 07:20
Sergio Cifuentes: Structured exercise after adjuvant chemotherapy  for colon cancer
Blog
Jun 2, 2025, 07:08
Roupen Odabashian: Benchmarking LLM Performance on Breast Oncology Multiple-Choice Questions
Insight
Jun 2, 2025, 07:04
Ibrahim Halil Sahin: The ATOMIC trial is out!
Blog
Jun 2, 2025, 06:59
Armando Orlandi: Day 3 of ASCO25 - Key Breast Cancer Updates
Blog
Jun 2, 2025, 06:54
Sarah Cannon Research Institute - Skip Burris was Honored with Endowed ASCO-Conquer Cancer Award in His Name
Insight
Jun 2, 2025, 06:41
Martin Zapata Laguado: New players in the management of mRCC patients
Insight
Jun 2, 2025, 06:19
Martin Zapata Laguado: KN564 maintain benefit on OS in ccRCC
Science
Jun 2, 2025, 06:09
Gerard Mawhinney: 14-year review of the Oxford Spinal Sarcoma Service on primary spinal tumour care
Blog
Jun 2, 2025, 05:45
ABC Global Alliance President, Fatima Cardoso, received the prestigious 2025 Yvonne Award for Lifetime Achievement in Oncology
Oncolibrary
Jun 2, 2025, 05:43
ctDNA Analysis in the Phase 3 NIAGARA Trial: Perioperative Durvalumab with Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
Science
Jun 2, 2025, 05:32
ALNEO Phase II Trial Highlights Promising Role of Perioperative Alectinib in Stage III Resectable ALK-Positive NSCLC
Science
Jun 2, 2025, 05:14
SAVANNAH Trial Highlights Synergistic Effect of Savolitinib and Osimertinib in EGFR-Mutant NSCLC with MET-Mediated Resistance